Latest on Ratan Tata’s investment platter is a cancer therapeutic startup!

Ratan Tata has made his fifth investment in a startup and this time it is a cancer therapeutic startup.

Tata has pumped money in Invictus Oncology, which utilises a supramolecular technology platform to design anti-cancer drugs that home into the tumour, and modulate the tumour immune response.

It has been validated in multiple cancer models.

"I have admired Ratan Tata's insights and astute assessment of technology for decades now, So I am thrilled he has invested in Invictus, which is not just developing ground-breaking innovations for cancer treatment, but is also among the very first startups based out of India to tread the path of novel discovery and biotech innovation," said Raghunath A. Mashelkar, co-founder of Invictus Oncology.

Year 2016 is going great for Tata as this was his fifth investment of this year.

Tata invested in Tracxn, DogSpot, FirstCry and CashKaro.

This Delhi-based also claims it has already developed a "deep pipeline of molecules," which address a $20 billion market opportunity in the oncology space.

The investment in Invictus Oncology will add to Tata’s rapidly expanding portfolio of almost 30 investments made over the last 12-18 months.